Idiopathic interstitial pneumonia
Supplements studied for idiopathic interstitial pneumonia.
Overview
N-Acetyl Cysteine (NAC) is the sole indexed supplement for idiopathic interstitial pneumonia (2 studies; DEX Score 36; very low effect size, medium evidence, medium trust). Idiopathic interstitial pneumonia belongs to a group of lung scarring diseases where NAC has been explored in small trials and broader reviews.
One small study reported improved lung function and disease markers after 12 weeks of NAC, but a review in a related fibrosis type found NAC did not reduce flare-ups or slow lung function decline. Evidence is uncertain and mixed across study types. See the evidence reviews below.
Effect graph
Subscribe to access all content
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to access all content
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
1 supplement for rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access all content
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in